ArticleFrontiers in oncology2022
MD2 Is a Potential Biomarker Associated with Immune Cell Infiltration in Gliomas.
Mengya Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleFrontiers in oncology2022
Mengya Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.